Immunization and Assay for Hemolysin Plaque-Forming
Cdgs.--Mice were immunized with 0.1 ml of a 20% suspension of sheep erythrocytes (approximately 1-2 X 108 cells) either intmperitoneally or intravenously. The number of hemolysin plaque-forming ceils per spleen was determined according to the technique of Cunningham and Szenberg (12) which is a modification of that of Jeme et al. (13) .
Preparation of Antilymphocyte Globulin (ALG).I--Two preparations of rabbit anti-mousc
lymphocyte globulin were used. The first, (A), was obtained from four rabbits by giving two injections of 109 washed thymus cells intravenously 14 days apart, followed by two further injections of 5 X 10 s thymus cells 4 and 6 wk later. The rabbits were bled 7 days after the last injection. The ability of the preparation to prolong the survival of skin grafts on mice has been described previously (14) . The second, (B), was obtained from three rabbits by injecting 109 washed mouse thymus cells intravenously at two-weekly intervals. The rabbits were bled 1 wk after both the second and the third injections and the sera pooled. Both preparations were absorbed with washed mouse erythrocytes and the second preparation was also absorbed with sheep erythrocytes. Neither antisera contained detectable antibodies against mouse gamma globulin. 2 The gamma globulin fraction of both ~ sera was obtained by ammonium sulfate precipitation and passage through a DEAE-cellulose column using 0.0175 M phosphate buffer pH 6.3. NRG was prepared slmil~rly. The final products were adjusted to 10 mg/ml and their purity checked by polyacrylamide gel electrophoresis and agar gel precipitation using anti-rabbit gamma globulin antiserum. Mice received a single intraperitoneal injection of 5 mg ALG or NRG.
Labeling of Thymus Cells with 51Cr.--Thymus ceils were washed once and then suspended in Eisen's balanced salt solution containing 10% heat-inactivated fetal calf serum. The cell concentration was 5 X 107/ml. SlCr, as Na2CrO4 in isotonic saline, was obtained from the Radiochemical Centre, Amersham, England. The specific activity varied between 150 and 263 p~//zg of chromium. The concentration of radioactivity was 1000#e/mi at the time of use. 20/zc of radioactivity was added per milliliter of the cell suspension. The ceils were then incubated in a water bath for 30 min at 37°C with occasional mixing. Cold Eisen's solution plus fetal calf serum was added and the tubes centrifuged. The cells were washed three times and finally resuspended in a concentration of about l0 s cells per milliliter. The amount of activity 1 The following abbreviations are used: ALS, antllymphocyte serum; ALG, antilymphocyte globulin; NRG, normal rabbit globulin; SRBC, sheep erythrocytes; PFC, hemolysin plaqueforming cells; NS, not significant; and SE, standard error.
2 Assayed by the sensitive microprecipitation technique using a range of 1~I-labded mouse myeloma proteins.
in a sample was determined and mice were then injected with about 5 X 107 cells containing 5000 counts per minute. 6 hr later the mice were bled and the spleens, livers, and lungs removed for organ counting. The amount of radioactivity present in these organs was determined using a Packard 'q'ricarb" scintillation counter.
S~is~c~ A.alysis.--The standard errors of the means were calculated. The P values were determined by Student's t test except where the variance ratio F test exceeded 0.05 probability. An appropriate modification of the t test was then utilized, s
RESULTS

Effect of Antilymphocyte Globulin on the Hemolysin Plaque-Forming Cell
Response to Sheep Erythrogytes.--The immunosuppressive capacity of our ALG preparations was tested in mice challenged with SRBC. In Fig. 1 are shown the results of experiments in which the animals were injected intraperitoneally with SRBC 48 hr after administration of 5 mg ALG/A. The controls were treated in an identical way but received NRG instead of ALG, or no rabbit globulin at all. In all groups the peak number of PFC produced in the spleen occurred on day 4 but it was 1 log10 lower in the case of ALG-treated mice.
Another group of mice was then used to determine when, in relation to the challenge with SRBC, the ALG preparation should be given in order to get a maximum immunosuppressive effect. The time of administration of ALG and NRG was therefore varied relative to the injection of SRBC and the PFC response per spleen was determined on day 4. As can be seen from Fig. 2 , ALG exerted significant immunosuppression but only when given before or simultaneously with the SRBC. By contrast NRG, whether given before, or together with SRBC, produced no depression of the PFC response.
Effects of Antilymphocyte Globulin on Hemolysin Plaque--Forming Cells In
Vitro.--Since the incubation of spleen cells containing PFC with specific anti-H2 isoanfisera and complement in vitro was associated with a marked reduction in the number of detectable PFC (6), it was of interest to determine whether incubation with ALG would produce a similar effect. Therefore, 10 million spleen cells from an immunized mouse were incubated with varying (Fig. 3) .
Effect of Injecting Th~rtnus Cells into ALG-treated
M~ce.--The effect of administering thymus cells on the immune response of ALG-treated mice was examined. I t was found that an intravenous injection of 100 million thymus cells had no effect on the response of A L G / A -t r e a t e d mice receiving SRBC intraperitoneatly although some increase was apparent in the case of A L G / B -treated recipients (Table I) . When the erythrocytes were given intravenously together with thymus cells, a marked increase in the response occurred in both ALG/A-and ALG/B-treated mice (Table I and Fig. 4) . A similar increase was achieved with 20 million normal spleen cells given intravenously (Fig. 4   t and Table II ), whereas 100 million bone marrow cells had no significant effect (Table II) . In addition, it can readily be seen from Table I that the response of ALG-treated mice not receiving thymus cells was greater when SRBC were given intravenously than intraperitoneally. In normal mice, however, neither thymus cells nor the route of injection of SRBC materially affected the PFC response (Table I and Significance level NS P < 0.01 P < 0.01 NS P < 0.01 P < 0.01 P < 0.001 NS NS interest to determine whether treatment with ALG affected the distribution of injected thymus cells and particularly the extent of their localization in the spleen. For this purpose, 50 million 51Cr-labeled thymus cells were injected into normal mice and mice pretreated with ALG/A 24 hr previously. The localization of radioactivity was determined 6 hr later. Approximately equal amounts of radioactivity were detected in the circulation in mice of both groups. In the spleens of ALG-treated mice, the amount of radioactivity was
Localization of ~Cr-labded Thymus Cells in ALG-treated Mice.--It was of
only half that recorded in the spleens of normal mice. Somewhat more radioactivity was present in the liver and lungs of ALG-treated mice than of normal mice (Fig. 6 ).
n-LLI Q~. 
Hemolysin Pique-Forming Cells Produced in Irradiated Mice Injected witk Spleen Cells from ALG-Treated
Mice.--The results obtained in Table I can be interpreted to mean that the spleens of ALG-treated mice were deficient in thymus-derived cells. Further support for this contention would be obtained ff it could be shown that irradiated recipients of spleen cells from ALG-treated donors produced fewer PFC in response to SRBC than irradiated recipients of the same number of normal spleen cells, and that additon of thymus cells could reverse this deficiency. Accordingly, 10 million spleen cells from normal or ALG-treated mice were injected intravenously together with SRBC into two groups of heavily irradiated syngeneic recipients. As can be seen in Fig. 7 and Table III, In other experiments, 50 million thymus ceils were mixed with different numbers of normal spleen cells ranging from half a million to 20 million and injected intravenously together with SRBC into irradiated syngeneic recipients. Thymus ceils did not enhance the response obtained with normal spleen ceils throughout this dose range (Fig. 8) . It is known that nonthymectomized irradiated mice protected with hemopoiefic cells, such as those in bone marrow and spleen of both normal and neonatally thymectomized donors, begin to recover their capacity to respond to SRBC after a period of 1-2 wk, and normal responsiveness is achieved after 5 wk. By contrast, only partial recovery occurs in mice thymectomized prior to irradiation and given either bone marrow from normal mice or spleen from neonatally thymectomized donors. Injection of normal spleen cells however, immediately confers some immunological capacity, presumably by providing immunologically competent cells already present in normal spleen (15) . An experiment was thus set up to determine whether spleen cells from ALGtreated mice could in time adoptively restore the response to SRBC in thymectomlzed irradiated hosts to the level achieved by normal spleen cells. Both thymectomized and nonthymectomized irradiated mice were given 10 million normal spleen cells, 10 million spleen cells from ALG-treated mice, or 10 million normal bone marrow cells. The mice were tested for their ability to respond to SRBC either immediately, or 2-4 wk later. The peak PFC response of mice challenged immediately after irradiation occurred on day 7 (Fig. 7) while that of irradiated mice challenged 2-4 wklater occurred on day 4 (unpublished work). The results are shown in Fig. 9 . In nonthymectomized mice the responses, at 2-4 wk posfirradiafion, were essentially similar whether the mice received normal spleen cells, spleen cells from ALG-treated mice, or normal bone marrow cells. On the other hand, the response of thymectomized irradiated mice given normal spleen cells remained significantly higher than that of mice given did not affect plaque formation by hemolysin-forming cells in vitro (Fig. 3) . The following experiment was performed in order to see whether A L G / A would affect antibody-forming cell precursors in vitro. Normal spleen cells were incubated at 37°C for 15 min in the presence of A L G / A at a concentra-tion of 100 #g/ml. The cells were washed twice and then 10 million spleen cells were injected together with SRBC into irradiated recipients with or without 5 X 107 thymus ceils. The number of PFC in the recipients' spleens was determined 7 days later and compared with that in mice given normal spleen cells incubated in the absence of ALG. Thymus ceils did not significantly elevate the response of spleen cells incubated in vitro with ALG (Table IV) . Thus, it appears that antibody-forming cell precursors can be eliminated from a population of spleen cells exposed to ALG in vitro. This is in contrast to the effect of ALG in vivo which is exerted selectively on thymus-derived cells. The immune response of mice to SRBC requires a participation by both thymus-derived cells and bone marrow-derived antibody-forming cell precursors (6, 7). The ability of thymus cells alone to restore to near-normal the reactivity of ALG-treated mice demonstrates that these mice are deficient primarily in thymus-derived ceils. The failure to obtain complete restoration of the response might indicate that ALG has also some effect in vivo, on antibody-forming cell precursors. This possibility appears unlikely for the following reasons: (a) bone marrow failed to increase the responsiveness to SRBC in both ALG-treated mice and in irradiated recipients of spleen cells from At, Gtreated donors; (b) ALG did not exert any immunosuppressive effect when given to mice after SRBC, that is presumably after the interaction between thymus-derived cells and antibody-forming ceil precursors had occurred; and (c) thymus cells restored the peak PFC response to SRBC in irradiated recipients of spleen cells from ALG-treated donors to a level similar to that observed in irradiated recipients of normal spleen cells. The fact that the PFC response was not completely restored to normal may therefore result not from any significant effect of ALG on PFC precursors, but from other effects on the spleen.
Thus the diminished localization of 51Cr-labeled thymus cells in the spleens of these mice suggests that some damage may have occurred in this organ. Since previous work had shown that lymphocytes, preincubated with ALG in vitro, were rapidly eliminated from the circulation (14) , the present finding that labeled cells remained circulating indicates that free ALG was no longer present in effective concentrations 24 hr after injection.
Levey and Medawar (16) observed that 200 million thymus cells given to ALS-treated mice 25 days after skin grafting, did not curtail graft survival. Thymus cells injected systemically do not localize to any significant extent in the peripheral lymph nodes (17)--the predominant site where sensitization to skin grafts occurs (18, 19) . The inability of thymus cells to hasten the rejection of skin grafts might simply be linked to a failure of these cells to make contact with graft antigens. Similarly, inadequate contact between thymus cells and antigen might explain why in our experiments the PFC response of ALGtreated recipients of thymus cells was increased to a greater extent when SRBC were given intravenously than intraperitoneally. Denman et al. (20) reported that a mixed inoculum of 150 million cells from spleen, lymph nodes, and bone marrow given intravenously did not enable ALG-treated mice to produce hemagglutlnins in response to intraperitoneal SRBC. In our experiments 20 million spleen cells elevated the PFC response of ALG-treated mice injected with SRBC intravenously. The failure of Denman et al. (20) to show an effect with these cells is difficult to explain particularly since lymph node cells home to peripheral lymph nodes after injection (21) and are effective in shortening the survival time of skin grafts on ALS-treated mice (16, 22) . Levey and Medawar (16) observed that a single injection of ALS was almost incapable of preventing sensitization when allogeneic lymphoid cells were injected intravenously, but could prevent sensitization resulting from an allogeneic skin graft. This was taken as evidence that ALS affected circulating lymphocytes to a greater extent than lymphocytes within lymphoid organs.
In these experiments, however, ALS was administered 1 day aflzr the mice had received either the allogeneic cells or the skin graft. It is known from the present experiments and those of Berenbaum (10) that ALG cannot depress the response to an injection of SRBC if it is given 1 day after antigen. The situation with allogeneic lymphoid cells may well be the same. On the other hand, the ability of ALS to prevent sensitization when given after the application of a skin graft might well be because sensitization in effect does not begin until at least 48 hr postgrafting (23, 24) . From our own results, it is apparent that ALG depressed the PFC response to SRBC to a greater extent when the antigen was given intraperitoneally than when given intravenously. This can be taken to indicate that ALG interferes with migration of thymusderived lymphocytes from the "periphery" to the lymphoid organs. It might explain why ALG is particularly effective in prolonging survival of organ grafts where it is likely that sensitization occurs as a result of contact between circulating lymphocytes and graft antigens (25) . It is also evident from our experiments that ALG does not affect solely "peripheral" lymphocytes but also alters the cell population within lymphoid organs, as shown by the poor PFC response of irradiated recipients of spleen cells from ALG-treated donors.
Levey and Medawar (16) also reported delayed recovery of reactivity against allogeneic skin grafts in irradiated recipients of a mixed inoculum of spleen and bone marrow cells obtained from mice that had received five injections of ALS. They argued from their results that ALS inactivated rather than eliminated lymphoid cells (even those cells within lymphoid organs); that the progeny of ALS-treated cells were incompetent for one or more generations; and that the inactivation eventually wore off in the irradiated recipient. Since, however, both bone marrow and spleen are a source of stem cells which can differentiate to immunologically competent cells in an irradiated, nonthymectomized host (15) , their data do not exclude the more likely possibility that competent cells were eliminated by ALS in the donor and that reactivity in the irradiated recipient returned only after new immunologically competent cells had differentiated from stem cells provided in the inoculum. Our experiments employing irradiated and thymectomized irradiated recipients of spleen cells from ALG-treated donors clearly show the importance of using thymectomized recipients in this type of experiment. They show in addition that ALG did not damage the stem cells since the return of reactivity occurred at the same rate in irradiated recipients of both normal bone marrow and spleen cells from ALGtreated donors. The peak response in thymectomized irradiated recipients of normal spleen cells was not significantly different whether the mice were challenged immediately after irradiation or 2 or 4 wk later. In thymectomized irradiated recipients of spleen cells from ALG-treated donors, the response increased as the time interval between irradiation and challenge was lengthened, but was always significantly lower than that in recipients of normal spleen cells. In fact it did not increase beyond that of thymectomized irradiaated mice protected with normal bone marrow. These findings do not support the idea that ALS temporarily inactivates lymphoid cells, whether by "blindfolding" or by "sterile activation" (25) . They are more consistent with the concept that the thymus-derived cells are eliminated. The data we have obtained in thymectomized irradiated mice are thus in general agreement with the results of others showing a prolongation of the immunosuppressive effect of ALS in thymectomized recipients (27, 28) .
Guttmann et al. (29) reported that the suppression of the response to SRBC in the rat by ALG was due to the presence of anti-SRBC antibodies within the globulin preparation and not to antilymphocyte antibodies. In our experiments, ALG/B was completely absorbed with SRBC and yet was still strongly immunosuppressive. This difference in the results might be due to the species used. Thus the response to SRBC in the rat is not depressed by neonatal thy-mectomy (30, 31) possibly because SRBC are stronger antigens in the rat which lacks the Forssman antigen than in the mouse which is Forssman positive (32) . If ALG produces the same effect as neonatal thymectomy, then one would not expect it to have, in the rat, a marked immunosuppressive effect with respect to the response to SRBC. Consistent with this, are our findings that the peak antibody response of mice to the flagella antigen of Salmonella adelaide was depressed neither by neonatal thymectomy nor by ALG/A. 4 The findings reported here suggest the generalization that, in vivo, the specific primary target cell for the imrrmnosuppressive activity of ALS is the thymus-derived antigen-reactive cell--the recirculating small lymphocyte which can initiate certain immune responsesuand that the effect of ALG is to eliminate these cells. While the mechanism of elimination is unknown, unpublished work from our laboratory suggests that opsonization followed by phagocytosis plays a major role. We have shown that, in vitro, antibody-forming cells precursors can be affected by ALG although there was no evidence for such an effect in vivo. The selective action of ALS on thymus-derived cells in vivo may be linked (a) to the specificity of the antibody raised during the preparation of ALS; 5 (b) to the greater susceptibility of thymus-derived cells, in contrast to other cell types, to the action of this antibody; and (c) to the probability that recirculating cells will be exposed to ALG more extensively than noncirculating cells. From these considerations, it would seem that the thymus may provide the best source of cells when attempts are made to purify ALG by elution methods, such as the one described by Woodruff (33) .
The capacity of thymus ceils to reconstitute ALG-treated mice supports the concept that cooperation between bone marrow-derived and thymusderived cells occurs in the immune response of mice to SRBC. The lack of effect of ALG on bone marrow-derived precursors might also explain why ALS does not necessarily cause lymphopenia for, as hypothesized in a preliminary communication (14) , the deficiency resulting from the elimination of thymus-derived lymphocytes might be offset by an excessive production of other types of lymphoid cells. The selective action of ALS makes it a useful tool in characterizing further the functions of the thymus-derived cells.
SUMMARY
In this series of papers it has been shown that the immune response of mice to sheep erythrocytes requires the participation of two classes of lymphoid ceils. Thymus-derived cells initially react with antigen and then interact with another dass of ceils, the antibody-forming cell precursors, to cause their differentiation to antibody-forming cells.
Antilymphocyte globulin depressed the ability of mice to respond to sheep erythrocytes. This effect was more marked when the antigen was injected intraperitoneally than intravenously, and occurred only when the antilymphocyte globulin was given before or simultaneously with antigen. Injection of thymus ceils restored to near normal the ability to respond to an intravenous injection of sheep erythrocytes. Spleen ceils from antilymphocyte globulintreated mice gave a weak adoptive immune response in irradiated recipients. The addition of thymus cells however enabled a response similar to that given by normal spleen cells.
When thymectomized irradiated recipients were used, normal spleen ceils continued to give a higher response to a challenge of sheep erythrocytes at 2 and 4 wk postirradiation than did spleen cells from ALG-treated donors. This result is more consistent with the notion that thymus-derived target cells are eliminated, rather than temporarily inactivated, by antilymphocyte globulin.
These findings suggest that, in vivo, antilymphocyte globulin acts selectively on the thymus-derived antigen-reactive ceils.
It is a pleasure to record our thanks to Miss B. Roberts and Miss M. Juchnowski for their excellent technical assistance. 
